Table 1.
Baseline clinical and biochemical characteristics (mITT population)
| Plasma-Lyte A | 0.9 % NaCl | ||
|---|---|---|---|
| n = 39 | n = 38 | ||
| Age*, months, mean | 45.9 | 34.2 | |
| Age group, n (%) | ≥6 months to ≤2 years | 8 (21) | 20 (53) |
| >2 to ≤5 years | 21 (54) | 11 (29) | |
| >5 to <11 years | 10 (26) | 7 (18) | |
| Weight*, kg | 15.8 ± 5.18 | 13.5 ± 6.80 | |
| Vomiting episodes | 8.9 ± 8.53 | 6.1 ± 5.92 | |
| Diarrhea episodes | 4.8 ± 4.77 | 6.8 ± 6.77 | |
| Capillary refill time*, seconds | 3.3 ± 0.50 | 2.8 ± 0.26 | |
| Bicarbonate, mEq/L | 16.9 ± 3.51 | 17.8 ± 2.82 | |
| Sodium, mEq/L | 137.0 ± 4.07 | 136.9 ± 2.93 | |
| Potassium, mEq/L | 4.4 ± 0.80 | 4.2 ± 0.67 | |
| Chloride, mEq/L | 103.0 ± 4.74 | 103.5 ± 4.19 | |
| BUN, mg/dL | 16.5 ± 7.17 | 14.6 ± 6.33 | |
| Creatinine*, mg/dL | 0.43 ± 0.13 | 0.37 ± 0.10 | |
| Glucose, mg/dL | 70.3 ± 21.26 | 74.4 ± 21.62 | |
| Gorelick dehydration scale, median (IQR) | 5 (5–6) | 5 (5–6) | |
| Ondansetron | 36 (92) | 29 (76) | |
| All analgesicsa | 25 (64) | 23 (61) | |
BUN blood urea nitrogen, IQR interquartile range
All data are presented as mean ± standard deviation unless otherwise indicated
aAcetaminophen, nonsteroidal anti-inflammatory drugs, and narcotics administered orally and/or by intravenous infusion
*P <0.05 PLA vs 0.9 % NaCl